ProCE Banner Activity

Individualizing Therapy for Patients With HR+/HER2- MBC

Slideset

Download these slides covering the latest evidence and recommendations on how to individualize current therapy for patients with HR+/HER2- MBC.

Released: December 06, 2024

Expiration: December 05, 2025

Share

Faculty

Jame Abraham

Jame Abraham, MD, FACP

Enterprise Chair and Professor of Medicine
Department of Hematology and Medical Oncology
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation